世界中の市場調査レポートを販売!当社に無いレポートもお探しします。

レポートナンバー 0000035864

肝疾患治療の世界市場規模調査・予測:治療タイプ別、疾患タイプ別、地域別の分析(2022年〜2029年)

Bizwit Research & Consulting LLP

Global Liver Disease Treatment Market Size study & Forecast, by Treatment Type (Antiviral Drugs, Immunosuppressants, Vaccines, Immunoglobulins, Corticosteroids, Targeted Therapy, Chemotherapy), by Disease Type (Hepatitis, Autoimmune Diseases, Non-alcoholic Fatty Liver Disease (NAFLD), Cancer, Genetic Disorders, Others) and Regional Analysis, 2022-2029

発刊日 2023/05/09

言語英語

体裁PDF/200ページ

ライセンス/価格200ページ

0000035864

Single
Enterprise

※ご請求は、お申込日のTTSレートで円換算し、消費税を加えた金額になります。
※本レポートは、英文です。PDF(電子媒体)での納品となります。
※本レポートは取り寄せとなりますので、申し込みからお届けまで、多少時間が掛かる場合がございます。

無料サンプル

  • サンプルはお問い合わせください。

レポート概要

肝臓は、潜在的に有害な体内毒素を処理し、排出することを唯一の役割とする重要な臓器です。肝臓に炎症を起こし、肝臓の正常な機能を阻害する可能性のある疾患は、肝臓病と呼ばれます。肝臓の疾患は、感染症、自己免疫疾患、市販薬の過剰使用、怪我、飲酒、その他の要因によって引き起こされることがあります。また、ある種の肝炎の治療には、免疫グロブリンが使用されます。非アルコール性脂肪性肝疾患(NAFLD)、肝硬変、肝炎、肝がんなどの肝疾患の有病率が世界的に上昇しているのは、アルコール摂取と不健康なライフスタイルが主な原因となっています。さらに、世界中で高齢者人口が増加していることも、疾病の機能不全を助長しています。その結果、遺伝性遺伝子疾患と上記に示したさまざまな肝疾患の両方で、病院への入院が急増しています。また、食生活の乱れや不健康な食事は、肥満の原因となり、さらに体重を増加させます。成人の脂肪性肝疾患の2大要因は、肥満とアルコール依存症です。過体重や肥満の結果、肝臓に脂肪が蓄積されます。その結果、炎症が持続し、肝臓が瘢痕化します(肝硬変とも呼ばれます)。肥満と非アルコール性脂肪性肝疾患は密接な関係にあります。過剰な脂肪は、インスリン抵抗性と炎症シグナルを引き起こします。高血圧、高コレステロール、過体重、糖尿病、インスリン抵抗性の患者さんは、脂肪性肝疾患を発症しやすいと言われています。

さらに、老人は成人よりも免疫力が低いため、肝臓の病気にかかりやすいと言われています。また、加齢により急性肝障害に対する脆弱性が高まることが示されています。このように、高齢化社会の進展は、予測期間中の市場成長をサポートすると予想されます。世界銀行によると、2015年には65歳以上の総人口の8%が生活しており、2021年にはその割合は10%に達しました。さらに、より優れた肝臓病治療法の開発のための研究開発活動への投資の高まりは、予測期間中に市場に有利な機会を生み出すと予想されます。しかし、肝疾患治療薬やワクチンに関連する厳しい規制当局の承認が、2022年から2029年の予測期間を通じて市場の成長を阻害しています。

世界の肝疾患治療市場調査の対象となる主要地域には、アジア太平洋、北アメリカ、ヨーロッパ、ラテンアメリカ、および世界のその他の地域含まれます。北アメリカは、主要企業の存在、アルコール消費量の増加、肥満や体重増加につながる不健康なライフスタイル、ヘルスケア支出の増加などにより、市場シェアにおいて世界的に優位な地域となっています。一方、アジア太平洋地域は、研究開発活動の増加、肝臓疾患の急増、満たされない医療需要、ヘルスケア分野への投資の増加などの要因により、予測期間中に最も高い成長率を示すと予想され、アジア太平洋地域の肝臓疾患治療薬市場にとって有利な成長見通しを生み出すと考えられています。

調査範囲

  • 調査企業
    ➣ Abbvie Inc.
    ➣ Abbott Laboratories
    ➣ Astellas Pharma Inc.
    ➣ Bristol-Myers Squibb
    ➣ Eli Lilly And Company
    ➣ Emergent Biosolutions Inc. (Cangene Biopharma)
    ➣ F. Hoffmann-La Roche Ag
    ➣ Gilead Sciences, Inc.
    ➣ Merck & Co. Inc.
    ➣ Viatris Inc.
  • 調査対象年
    ➣ 履歴データ - 2019-2020-2021
    ➣ 推定基準年 - 2021
    ➣ 予測期間 - 2022-2029

この調査の目的は、近年のさまざまなセグメントおよび国の市場規模を定義し、今後数年間の市場規模を予測することです。この報告書は、調査に参加している国の業界の定性的および定量的側面の両方を組み込むように設計されています。

このレポートは、市場の将来の成長を定義する推進要因や課題などの重要な側面に関する詳細情報も提供します。さらに、競争環境と主要企業の製品提供の詳細な分析とともに、利害関係者が投資できるミクロ市場における潜在的な機会も組み込まれています。

  • 市場セグメント
    ➣ 治療タイプ別
      ◇ 抗ウイルス薬
      ◇ 免疫抑制薬
      ◇ ワクチン
      ◇ 免疫グロブリン
      ◇ 副腎皮質ホルモン剤
      ◇ 標的治療薬
      ◇ 化学療法
    ➣ 疾患タイプ別
      ◇ 肝炎
      ◇ 自己免疫疾患
      ◇ 非アルコール性脂肪性肝疾患(NAFLD)
      ◇ がん
      ◇ 遺伝性疾患
      ◇ その他
    ➣ 地域別
      ◇ 北アメリカ
       ✓ アメリカ
       ✓ カナダ
      ◇ ヨーロッパ
       ✓ イギリス
       ✓ ドイツ
       ✓ フランス
       ✓ スペイン
       ✓ イタリア
       ✓ その他のヨーロッパ
      ◇ アジア太平洋地域
       ✓ 中国
       ✓ インド
       ✓ 日本
       ✓ オーストラリア
       ✓ 韓国
       ✓ その他のAPAC
      ◇ ラテンアメリカ
       ✓ ブラジル
       ✓ メキシコ
       ✓ その他のラテンアメリカ
      ◇ 世界のその他の地域

レポート詳細

目次

Table of Contents

Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2019-2029 (USD Billion)
1.2.1. Liver Disease Treatment Market, by Region, 2019-2029 (USD Billion)
1.2.2. Liver Disease Treatment Market, by Treatment Type, 2019-2029 (USD Billion)
1.2.3. Liver Disease Treatment Market, by Disease Type, 2019-2029 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption

Chapter 2. Global Liver Disease Treatment Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates

Chapter 3. Global Liver Disease Treatment Market Dynamics
3.1. Liver Disease Treatment Market Impact Analysis (2019-2029)
3.1.1. Market Drivers
3.1.1.1. Growing incidence of liver diseases
3.1.1.2. Rising alcohol consumption and poor dietary habits
3.1.1.3. Surge in geriatric population
3.1.2. Market Challenges
3.1.2.1. Stringent regulatory approvals related to liver disease treatment drugs and vaccines
3.1.3. Market Opportunities
3.1.3.1. Rising Investment in R&D

Chapter 4. Global Liver Disease Treatment Market Industry Analysis
4.1. Porter's 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.2. Futuristic Approach to Porter's 5 Force Model (2019-2029)
4.3. PEST Analysis
4.3.1. Political
4.3.2. Economical
4.3.3. Social
4.3.4. Technological
4.4. Top investment opportunity
4.5. Top winning strategies
4.6. Industry Experts Prospective
4.7. Analyst Recommendation & Conclusion

Chapter 5. Risk Assessment: COVID-19 Impact
5.1. Assessment of the overall impact of COVID-19 on the industry
5.2. Pre COVID-19 and post COVID-19 Market scenario

Chapter 6. Global Liver Disease Treatment Market, by Treatment Type
6.1. Market Snapshot
6.2. Global Liver Disease Treatment Market by Treatment Type, Performance - Potential Analysis
6.3. Global Liver Disease Treatment Market Estimates & Forecasts by Treatment Type 2019-2029 (USD Billion)
6.4. Liver Disease Treatment Market, Sub Segment Analysis
6.4.1. Antiviral Drugs
6.4.2. Immunosuppressants
6.4.3. Vaccines
6.4.4. Immunoglobulins
6.4.5. Corticosteroids
6.4.6. Targeted Therapy
6.4.7. Chemotherapy

Chapter 7. Global Liver Disease Treatment Market, by Disease Type
7.1. Market Snapshot
7.2. Global Liver Disease Treatment Market by Disease Type, Performance - Potential Analysis
7.3. Global Liver Disease Treatment Market Estimates & Forecasts by Disease Type 2019-2029 (USD Billion)
7.4. Liver Disease Treatment Market, Sub Segment Analysis
7.4.1. Hepatitis
7.4.2. Autoimmune Diseases
7.4.3. Non-alcoholic Fatty Liver Disease (NAFLD)
7.4.4. Cancer
7.4.5. Genetic Disorders
7.4.6. Others

Chapter 8. Global Liver Disease Treatment Market, Regional Analysis
8.1. Liver Disease Treatment Market, Regional Market Snapshot
8.2. North America Liver Disease Treatment Market
8.2.1. U.S. Liver Disease Treatment Market
8.2.1.1. Treatment Type breakdown estimates & forecasts, 2019-2029
8.2.1.2. Disease Type breakdown estimates & forecasts, 2019-2029
8.2.2. Canada Liver Disease Treatment Market
8.3. Europe Liver Disease Treatment Market Snapshot
8.3.1. U.K. Liver Disease Treatment Market
8.3.2. Germany Liver Disease Treatment Market
8.3.3. France Liver Disease Treatment Market
8.3.4. Spain Liver Disease Treatment Market
8.3.5. Italy Liver Disease Treatment Market
8.3.6. Rest of Europe Liver Disease Treatment Market
8.4. Asia-Pacific Liver Disease Treatment Market Snapshot
8.4.1. China Liver Disease Treatment Market
8.4.2. India Liver Disease Treatment Market
8.4.3. Japan Liver Disease Treatment Market
8.4.4. Australia Liver Disease Treatment Market
8.4.5. South Korea Liver Disease Treatment Market
8.4.6. Rest of Asia Pacific Liver Disease Treatment Market
8.5. Latin America Liver Disease Treatment Market Snapshot
8.5.1. Brazil Liver Disease Treatment Market
8.5.2. Mexico Liver Disease Treatment Market
8.5.3. Rest of Latin America Liver Disease Treatment Market
8.6. Rest of The World Liver Disease Treatment Market

Chapter 9. Competitive Intelligence
9.1. Top Market Strategies
9.2. Company Profiles
9.2.1. Abbvie Inc.
9.2.1.1. Key Information
9.2.1.2. Overview
9.2.1.3. Financial (Subject to Data Availability)
9.2.1.4. Product Summary
9.2.1.5. Recent Developments
9.2.2. Abbott Laboratories
9.2.3. Astellas Pharma Inc.
9.2.4. Bristol-Myers Squibb
9.2.5. Eli Lilly And Company
9.2.6. Emergent Biosolutions Inc. (Cangene Biopharma)
9.2.7. F. Hoffmann-La Roche Ag
9.2.8. Gilead Sciences, Inc.
9.2.9. Merck & Co. Inc.
9.2.10. Viatris Inc.

Chapter 10. Research Process
10.1. Research Process
10.1.1. Data Mining
10.1.2. Analysis
10.1.3. Market Estimation
10.1.4. Validation
10.1.5. Publishing
10.2. Research Attributes
10.3. Research Assumption

LIST OF TABLES
TABLE 1. Global Liver Disease Treatment Market, report scope
TABLE 2. Global Liver Disease Treatment Market estimates & forecasts by Region 2019-2029 (USD Billion)
TABLE 3. Global Liver Disease Treatment Market estimates & forecasts by Treatment Type 2019-2029 (USD Billion)
TABLE 4. Global Liver Disease Treatment Market estimates & forecasts by Disease Type 2019-2029 (USD Billion)
TABLE 5. Global Liver Disease Treatment Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 6. Global Liver Disease Treatment Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 7. Global Liver Disease Treatment Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 8. Global Liver Disease Treatment Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 9. Global Liver Disease Treatment Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 10. Global Liver Disease Treatment Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 11. Global Liver Disease Treatment Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 12. Global Liver Disease Treatment Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 13. Global Liver Disease Treatment Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 14. Global Liver Disease Treatment Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 15. U.S. Liver Disease Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 16. U.S. Liver Disease Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 17. U.S. Liver Disease Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 18. Canada Liver Disease Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 19. Canada Liver Disease Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 20. Canada Liver Disease Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 21. UK Liver Disease Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 22. UK Liver Disease Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 23. UK Liver Disease Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 24. Germany Liver Disease Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 25. Germany Liver Disease Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 26. Germany Liver Disease Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 27. France Liver Disease Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 28. France Liver Disease Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 29. France Liver Disease Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 30. Italy Liver Disease Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 31. Italy Liver Disease Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 32. Italy Liver Disease Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 33. Spain Liver Disease Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 34. Spain Liver Disease Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 35. Spain Liver Disease Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 36. RoE Liver Disease Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 37. RoE Liver Disease Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 38. RoE Liver Disease Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 39. China Liver Disease Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 40. China Liver Disease Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 41. China Liver Disease Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 42. India Liver Disease Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 43. India Liver Disease Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 44. India Liver Disease Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 45. Japan Liver Disease Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 46. Japan Liver Disease Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 47. Japan Liver Disease Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 48. South Korea Liver Disease Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 49. South Korea Liver Disease Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 50. South Korea Liver Disease Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 51. Australia Liver Disease Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 52. Australia Liver Disease Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 53. Australia Liver Disease Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 54. RoAPAC Liver Disease Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 55. RoAPAC Liver Disease Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 56. RoAPAC Liver Disease Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 57. Brazil Liver Disease Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 58. Brazil Liver Disease Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 59. Brazil Liver Disease Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 60. Mexico Liver Disease Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 61. Mexico Liver Disease Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 62. Mexico Liver Disease Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 63. RoLA Liver Disease Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 64. RoLA Liver Disease Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 65. RoLA Liver Disease Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 66. Row Liver Disease Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 67. Row Liver Disease Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 68. Row Liver Disease Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 69. List of secondary sources, used in the study of global Liver Disease Treatment Market
TABLE 70. List of primary sources, used in the study of global Liver Disease Treatment Market
TABLE 71. Years considered for the study
TABLE 72. Exchange rates considered

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

LIST OF FIGURES
FIG 1. Global Liver Disease Treatment Market, research methodology
FIG 2. Global Liver Disease Treatment Market, Market estimation techniques
FIG 3. Global Market size estimates & forecast methods
FIG 4. Global Liver Disease Treatment Market, key trends 2021
FIG 5. Global Liver Disease Treatment Market, growth prospects 2022-2029
FIG 6. Global Liver Disease Treatment Market, porters 5 force model
FIG 7. Global Liver Disease Treatment Market, pest analysis
FIG 8. Global Liver Disease Treatment Market, value chain analysis
FIG 9. Global Liver Disease Treatment Market by segment, 2019 & 2029 (USD Billion)
FIG 10. Global Liver Disease Treatment Market by segment, 2019 & 2029 (USD Billion)
FIG 11. Global Liver Disease Treatment Market by segment, 2019 & 2029 (USD Billion)
FIG 12. Global Liver Disease Treatment Market by segment, 2019 & 2029 (USD Billion)
FIG 13. Global Liver Disease Treatment Market by segment, 2019 & 2029 (USD Billion)
FIG 14. Global Liver Disease Treatment Market, regional snapshot 2019 & 2029
FIG 15. North America Liver Disease Treatment Market 2019 & 2029 (USD Billion)
FIG 16. Europe Liver Disease Treatment Market 2019 & 2029 (USD Billion)
FIG 17. Asia Pacific Liver Disease Treatment Market 2019 & 2029 (USD Billion)
FIG 18. Latin America Liver Disease Treatment Market 2019 & 2029 (USD Billion)
FIG 19. Global Liver Disease Treatment Market, company Market share analysis (2021)

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

この商品のレポートナンバー

0000035864

TOP